Skip to main content
logo
Edwards Lifesciences Corporation (EW)
NYSE: EW · Real-Time Price · USD
89.90
+0.12 (0.13%)
At close: Sep 4, 2026, 4:00 PM EDT
89.87
-0.03 (-0.03%)
After-hours: Sep 4, 2026, 7:58 PM EDT

Edwards Lifesciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
1,0051,0744,1751,4021,5221,503
Depreciation & Amortization
165.5156.6143.2122139.6134.8
Loss (Gain) From Sale of Assets
-33.9-33.9-3,348---
Asset Writedown & Restructuring Costs
4040--55.14
Loss (Gain) From Sale of Investments
14.7146.9-55-51.5-36.8
Stock-Based Compensation
168158.1162.3139.4126.8109.3
Other Operating Activities
289.9-100.6-287.3-264.6-255.3-127.6
Change in Accounts Receivable
-82.5-23121.2-141.2-84.1-91.1
Change in Inventory
-15.950.7-256.1-289-213.419
Change in Accounts Payable
171.4395.189.5146-21.4195.2
Change in Income Taxes
101.3-141.8-186.7-5.8-5.662
Change in Other Net Operating Assets
-103.1-126.4-27.2-236.3-96.9-39.8
Operating Cash Flow
1,7201,595542.3895.81,2181,732
Operating Cash Flow Growth
116.42%194.16%-39.46%-26.46%-29.67%64.29%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-286.7-260.2-252.4-253-244.6-325.8
Cash Acquisitions
-33.7--1,062-95.2--
Divestitures
42.542.53,927---
Sale (Purchase) of Intangibles
---30-13.3-20.2-4
Investment in Securities
-527.6-321.8-148.5624.5689.8-1,350
Other Investing Activities
-106.6-173.4-121.8-89.2-172.7-42.6
Investing Cash Flow
-912.1-712.92,313173.8252.3-1,723

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-----5.2
Long-Term Debt Repaid
------7
Net Debt Issued (Repaid)
------1.8
Issuance of Common Stock
189.7174.1179.5169.9146.4158.6
Repurchase of Common Stock
-1,154-893.4-1,159-879.6-1,727-512.8
Other Financing Activities
-238.3-237.5-3.1-1.3-3.8-0.3
Financing Cash Flow
-1,203-956.8-983-711-1,585-356.3

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
14.5-44.838.616.819.213.9
Net Cash Flow
-380.3-119.31,911375.4-94.8-332.8

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
1,4341,335289.9642.8973.61,406
Free Cash Flow Growth
143.85%360.50%-54.90%-33.98%-30.77%117.26%
Free Cash Flow Margin
22.01%22.00%5.33%12.83%21.81%26.88%
Free Cash Flow Per Share
2.472.280.481.051.562.23
Levered Free Cash Flow
1,2321,1701,339566.93776.731,009
Unlevered Free Cash Flow
1,2451,1821,351577.93788.731,020

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
20.220.219.619.919.320.2
Cash Income Tax Paid
220.1490.41,166444.9466.7182.5
Change in Working Capital
71.2154.6-259.3-526.3-421.4145.3
SEC Filings: 10-K · 10-Q